Calidi Biotherapeutics
CLDI
CLDI
42 hedge funds and large institutions have $204M invested in Calidi Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.01% more ownership
Funds ownership: 0.74% → 0.75% (+0.01%)
Holders
42
Holding in Top 10
–
Calls
$602K
Puts
–
Top Buyers
| 1 | +$7.46M | |
| 2 | +$5.48M | |
| 3 | +$2.89M | |
| 4 |
SC
Sculptor Capital
New York
|
+$2.63M |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$2.52M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$7.43M | |
| 3 | -$4.32M | |
| 4 |
PCM
Pinz Capital Management
New York
|
-$564K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$275K |